Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa dose-ranging trial of Xuesaitong Soft Capsules for nonischemic retinal vein occlusion
ChiCTR-IIR-17013018Phase 2Recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Oct 2017
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of panax notoginseng in Vein occlusion (RVO) (3 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoint: Best corrected visual acuity change from baseline. Started Oct 2017; status: recruiting.
02
Drugs
panax notoginseng
03
Conditions
Vein occlusion (RVO)
Beyond the preview
Go deeper on ChiCTR-IIR-17013018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-17013018.